Dxcover

📍 GLASGOW, United Kingdom🗓 Founded 2016👥 28 employees💰 Last funded Dec 2024
Medical Equipment Manufacturing🌐 dxcover.com
Website LinkedIn
Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company has pioneered the early detection and identification of cancer employing infrared spectroscopy of circulating pan-omic biomarkers. The company has generated compelling clinical data with high accuracy detection of Stage I and Stage II cancers. Dxcover is based in Scotland, United Kingdom and is establishing operations in the USA.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Dxcover?
Dxcover has 2 investors on record on gritt.io and 2 late-stage investors.
When did Dxcover last raise funding?
The most recent investment in Dxcover recorded on gritt.io was in December 2024.
When was Dxcover founded?
Dxcover was founded in 2016.
What industry is Dxcover in?
Dxcover operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Dxcover based?
Dxcover is headquartered in GLASGOW, United Kingdom.